Denmark has suspended the use of the AstraZeneca vaccine due to concerns about links to an increased risk of blood clots, the Danish health authority said Thursday

Use of the vaccine will now be halted for at least 14 days after several serious cases of blood clots were reported in people who received the shot, national broadcaster DR


The Danish Medicines Agency said in a statement it was investigating the death of a person who was vaccinated with the AstraZeneca shot and developed a blood clot

Danish Health Minister Magnus Heunicke posted a message on Twitter confirming that the use of the AstraZeneca vaccine had been discontinued “after a signal of possible serious side effects in the form of fatal blood clots”

“It is not currently possible to infer whether there is a link,” he added, “We acted early, it needs a thorough investigation”

A little more than 142 in total000 people in Denmark, which has a population of around six million, were injected with the vaccine by AstraZeneca, a British-Swedish company

As of Feb 28, the UK had administered 97 million doses of the AstraZeneca vaccine The UK Medicine Watchdog, the regulator for medicines and health products, has not publicly set any concerns about blood clots “The number and types of suspected side effects reported to date are compared to other types of vaccines routinely used not unusual, “said the agency

In the statement from the Danish Medicines Agency, Tanja Erichsen, a department head, said: “We do not yet know whether the blood clots and the Danish death are caused by the vaccine, but it is currently being thoroughly investigated to be on the safe side”

The Danish health authority pointed to several such cases that have been reported across Europe and said it would await further investigation by the European Medicines Agency, the European Union’s medicines regulatory authority

On Wednesday, the European agency announced there was no evidence that two Austrian cases – one in which a patient died after blood clots formed and another in which a patient with a similar condition went into Was hospitalized – related to the use of the vaccine

The use of the specific batch of vaccine that led to the cases in Austria has been suspended in the country and subsequently in Estonia, Latvia, Lithuania and Luxembourg, but the European Medicines Agency said a quality defect was “unlikely” but said that the batch would be further investigated

Soren Brostrom, Director of the National Board of Health in Denmark, said: “We are in the middle of the largest and most important vaccination rollout in Danish history. And now we need all the vaccines we can get. So it is not an easy decision to stop one of the vaccines ”

“But precisely because we vaccinate so many,” he added, “we also have to react in good time if we become aware of possible serious side effects”


World News – FI – Denmark suspends use of AstraZeneca shots over blood clot concerns